Corrigendum to "Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis" [AUTREV 18-11 (2019) 102395]
Autoimmun Rev. 2020 Apr;19(4):102503.
doi: 10.1016/j.autrev.2020.102503.
Epub 2020 Mar 10.
1 Section of Rheumatology, Yale School of Medicine, New Haven, CT, USA.
2 CHRU de Nancy, Department of Internal Medicine, F-54000 Nancy, France; Université de Lorraine, Inserm UMR_S 1116, F-54000 Nancy, France.
3 Université de Lorraine, Inserm UMR_S 1116, F-54000 Nancy, France; CHRU de Nancy, Vascular Medicine Division and Regional Competence Centre For Rare Vascular and Systemic Autoimmune Diseases, F-54000 Nancy, France.
4 Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA.
5 Université de Lorraine, Inserm UMR_S 1116, F-54000 Nancy, France; CHRU de Nancy, Vascular Medicine Division and Regional Competence Centre For Rare Vascular and Systemic Autoimmune Diseases, F-54000 Nancy, France. Electronic address: s.zuily@chru-nancy.fr.